Cell Regeneration Medicine Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Overview and Scope

Cell regeneration medicine refers to a branch of medical science and technology that focuses on harnessing the natural ability of cells to repair, replace and regenerate damaged or diseased tissues and organs within the human body. It involves using various cellular therapies, tissue engineering techniques and regenerative medicine approaches to promote healing and restore functionality to damaged areas.

Sizing and Forecast

The cell regeneration medicine market size has grown rapidly in recent years. It will grow from $36.08 billion in 2023 to $41.83 billion in 2024 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to aging population, prevalence of chronic diseases, growing government and corporate funding, growing demand for functional regenerative medicine products.

The cell regeneration medicine market size is expected to see rapid growth in the next few years. It will grow to $71.86 billion in 2028 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to rising demand for regenerative medicine products from the horeca sector, shortage of organs for transplantation, increasing r&d activities, growing demand for gene therapies. Major trends in the forecast period include advanced therapies, clinical trial expansion, tissue engineering and 3d bioprinting, exosome-based therapies, personalized medicine.

To access more details regarding this report, visit the link:

https://www.thebusinessresearchcompany.com/report/cell-regeneration-medicine-global-market-report

Segmentation & Regional Insights

The cell regeneration medicine market covered in this report is segmented –

1) By Product: Therapeutics; Tools; Banks; Services

2) By Therapeutic Category: Dermatology; Musculoskeletal; Immunology And Inflammation; Oncology; Cardiovascular; Ophthalmology; Other Therapeutic Categories

3) By End-User: Hospitals And Clinics; Commercial Industries; Government And Academic Research Institutes

North America was the largest region in the cell regeneration medicine market in 2023. The regions covered in cell regeneration medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12884&type=smp

Major Driver Impacting Market Growth

Widespread adoption of organ transplantation is expected to propel the cell regeneration medicine market going forward. Organ transplantation is a medical procedure in which an organ is removed from one body and placed in the body of a recipient to replace a damaged or missing organ. Organ transplantation has become more popular as it helps provide longer lives and helps avoid medical procedures such as dialysis. Cell regenerative medicine offers potential advancements in organ transplantation by focusing on repairing and regenerating damaged tissues or organs. For instance, in January 2023, according to the United Network for Organ Sharing, a US-headquartered scientific and educational organization, around 42,887 organ transplants were performed in the United States in 2022, an increase of 3.7% compared to 2021. Therefore, the widespread adoption of organ transplants will drive the cell regeneration medicine market.

Key Industry Players

Major players in the cell regeneration medicine market are Pfizer Inc., Johnson & Johnson, F.Hoffman-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Medtronic PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., ViaCord LLC, Stryker Corporation, Zimmer Biomet Holdings Inc., Cook Biotech Inc., Integra LifeSciences Holdings Corporation, NuVasive Inc., Organogenesis Holdings Inc., AMAG Pharmaceuticals Inc., Takara Bio Inc., MiMedx Group Inc., Vericel Corporation, Mesoblast Limited, Osiris Therapeutics Inc., Guanhao Biotech Co. Ltd., CordLife Group Limited, FUJIFILM Cellular Dynamics Inc., Cesca Therapeutics Inc., U.S. Stem Cell Inc., Cytori Therapeutics Inc.

The cell regeneration medicine market report table of contents includes: